AlphaMol Science advances several  "first-in-class" in-house drug discovery projects. The pipelines include dual functional anti-cancer drug, infections, less side effect painkiller, cancer and metabolism. With the advantages of outstanding GPCR-oriented drug discovery platform in AlphaMol, we managed to speed up the "first-in-class" preclinical drug discovery processes in an ultimately efficient way.  It saves 80-99% costs in both time and finance.